Identity
- Security key
- 23237
- Ticker
- VBIO
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2021-11-11
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- VBIO
Detail
Enriched 2026-08-14 20:47
- Market cap
- $938,184.53
- Shares outstanding (class)
- 4,151,259
- Shares outstanding (weighted)
- 4,151,259
- SIC
- 3845 ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
- Employees
- 52
- Location
- SAN ANTONIO, TX
- Homepage
- https://www.tivichealth.com
- Description
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.